Cytokine production in thromboangiitis obliterans patients: New evidence for an immune-mediated inflammatory disorder

Clinical and Experimental Rheumatology

Volumn 23, Issue 2, 2005, Pages 219-226

  Slavov, Emil S ^a   Stanilova, Spaska A ^a   Petkov, Dimitar P ^a   Dobreva, Zlatka G ^a  

^a TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

Apoptosis; IL 10; IL 12; IL 6; Immune complex; PBMC; TAO

Indexed keywords

ACRIDINE ORANGE; DEXAMETHASONE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; PLANT EXTRACT; POKEWEED MITOGEN;

ADULT; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; BLOOD SAMPLING; BUERGER DISEASE; CELL CULTURE; CELL ISOLATION; CELL STIMULATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CUSCUTA; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IN VITRO STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; ANTIGEN-ANTIBODY COMPLEX; APOPTOSIS; CARRIER PROTEINS; CELL NUCLEUS; CULTURE MEDIA, CONDITIONED; CUSCUTA; DEXAMETHASONE; FEMALE; HUMANS; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; POKEWEED MITOGENS; THROMBOANGIITIS OBLITERANS;

EID: 18644367768     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. STONE JK, NOUSARI HC: "Essential" cutaneous vasculitis: what every rheumatologist should know about vasculitis of the skin. Curr Opin Rheumatol 2001; 13: 23-34.
2. HOPE B, LU JT, THISTLEWAITE P, YI ES, MAHMUD E: Beyond peripheral arteries in Buerger's disease: angiographic consideration in thromboangiitis obliterans. Catheter Cardiovasc Interv 2002; 57: 363-6.
3. MILLS JL Sr: Buerger's disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg 2003; 16: 179-89.
4. KROGER K, KREUZFELDER E, MOSER C, SANTOSA F, BUSS C, GROSSE-WILDE H: Thrombangitis obliterans: leucocyte subpopulations and circulating immune complexes. Vasa 2001; 30: 189-94.
5. CZARNACKI M, ZDROJOWY K, ADAMIEC R: Review of current etiopathogenic data of Buerger disease. Pol Merkuriusz Lek 2002; 13: 263-5.
6. ADAR R, PAPA MZ, HALPERN Z et al.: Cellular sensitivity to collagen in thromboangiitis obliterans. NEJM 1983; 308: 1113-6.
7. MASLOWSKI L, MCBANE R, ALEXEWICZ P, WYSOKINSKI WE: Antiphospholipid antibodies in thromboangiitis obliterans. Vasc Med 2002; 7: 257-64.
8. EICHHORN J, SIMA D, LINDSCHAU C et al.: Antiendothelial cell antibodies in thromboangiitis obliterans. Am J Med Sci 1998; 315: 17-23.
9. MEHRA NK, JAINI R: Immunogenetics of peripheral arteriopathies. Clin Hemorheol Microcirc 2000; 23: 225-32.
10. HALACHEVA K, GULUBOVA MV, MANOLOVA I, PETKOV D: Expression of ICAM-1, VCAM-1, E-selectin and TNF-alpha on the endothelium of femoral and iliac arteries in thromboangiitis obliterans Acta Histochem 2002; 104: 177-84.
11. ADAR R, PAPA MZ, SCHNEIDERMAN J: Thromboangiitis obliterans: an old disease in need of a new look. Int J Cardiol 2000; 75 (Suppl. 1): S167-173.
12. FUJIOKA A, YAMAMOTO T, TAKASU H et al.: The analysis of mRNA expression of cytokines from skin lesions in Churg-Strauss syndrome. J Dermatol 1998; 25: 171-7.
13. EVEREKLIOGLU C, ER H, TURKOZ Y, CEKMEN M: Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased in patients with Behcet's disease. Mediators Inflamm 2002; 11: 87-93.
14. NALBANT S, KOC B, TOP C et al.: Hypersensitivity vasculitis and cytokines. Rheumatol Int 2002; 22: 244-8.
15. DAY CJ, HEWINS P, SAVAGE CO: New developments in the pathogenesis of ANCA-associated vasculitis. Clin Exp Rheumatol 2003; 21 (Suppl. 32): S35-S48.
16. SHIONOYA S: Buerger's disease (Thromboangiitis obliterans). In RUTHERFORD R (Ed.): Vascular Surgery, 4th ed., Philadelphia, W.B. Saunders Co., 1995: 235-45.
17. STANILOVA SA, SLAVOV ES: Comparative study of circulating immune complexes quantity detection by three assays - CIF-ELISA, C1q-ELISA and anti-C3 ELISA. J Immunol Methods 2001; 253: 13-21.
18. STANILOVA SA, SLAVOV ES: New ELISA kits using C3 binding glycoprotein from Cuscuta europea detect mainly IgMCIC in rheumatoid arthritis and progressive systemic sclerosis, but not in systemic lupus erythematosus. Clin Dev Immunol 2003; 10: 111-7.
19. EVANS D, TILBY M, DIVE C: Differential sensitivity to the induction of apoptosis by cisplatin in proliferating and quiescent immature rat thymocytes is independent of the levels of drug accumulation and DNA adduct formation. Cancer Res 1994; 54: 1596-603.
20. ZHELEV ZHD, STANILOVA SA, CARPENTER BG: Isolation, partial characterization and complement inhibiting activity of a new glycoprotein from Cuscuta europea. Biochem. Bioph Res Comm 1994; 202: 186-94.
21. RAZIUDDIN S, AL-DALAAN A, BAHABRI S, SIRAJ AK, AL-SEDAIRY S: Divergent cytokine production in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol 1998; 25: 329-33.
22. FRASSANITO MA, DAMMACCO R, CAFFORIO P, DAMMACCO F: Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999; 42: 1967-74.
23. SUNDY JS, HAYNES BF: Cytokines and adhesion molecules in the pathogenesis of vasculitis. Curr Rheumatol Rep 2000; 2: 402-10.
24. TURAN B, GALLATI H, ERDI H, GURLER A, MICHEL BA, VILLIGER PM: Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 1997, 24: 128-32.
25. SCHONERMARCK U, CSERNOK E, TRABANDT A, HANSEN H, GROSS WL: Circulating cytokines and soluble CD23, CD26 and CD30 in ANCA-associated vasculitides. Clin Exp Rheumatol 2000; 18: 457-63.
26. SULLIVAN KE, CUTILLI J, PILIERO LM et al.: Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2000; 7: 920-4.
27. PRABHAKAR U, EIRIKIS E, DAVIS HM: Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods 2002; 260: 207-18.
28. HSIEH C, MACATONIA SE, TRIPP CS, WOLF SF, O'GARRA A, MURPHY KM: Development of Th1 CD4+ T cells through IL-12 produced by Listeria - induced macrophage. Science 1993; 260: 547.
29. GERMANN T, GATELY MK, SCHOENHAUT DS et al.: Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur J Immunol 1993; 23: 1762-70.
30. HEUFLER C, KOCH F, STANZL U et al.: Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol 1996; 26: 659-68.
31. SOIFFER CJR, ROBERTSON JM, MURRAY C, COCHRAN K, RITZ J: Interleukin-12 augments cytolytic activity of peripheral blood lymphocytes from patients with hematologic and solid malignancies. Blood 1993; 82: 2790-6.
32. MAGRAM J, CONNAUGHTON SE, WARRIER RR et al.: IL-12-deficient mice are defective in IFN-gamma production and type 1 cytokine responses. Immunity 1996; 4: 471-81.
33. BARTON BE: IL-6: insights into novel biological activities. Clin Immunol Immunopathol 1997; 85: 16-20.
34. OPAL MS, DEPALO VA: Anti-inflammatory cytokines. CHEST 2000, 117: 1162-72.
35. POPA ER, FRANSSEN CF, LIMBURG PC, HUITEMA MG, KALLENBERG CG, TERVAERT JW: In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum 2002; 46: 1894-904.
36. LUDVIKSSON B, SNELLER M, CHUA K et al.: Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-Type T cell cytokine pattern: reversal with IL-10. J Immunol 1998; 160: 3602-9.
37. LAMPRECHT P, KUMANOVICS G, MUELLER A et al.: Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapy. Clin Exp Immunol 2002; 128: 181-6.
38. KATAYAMA K, MATSUBARA T, FUJIWARA M, KOGA M, FURUKAWA S: CD14+CD16+ monocyte subpopulation in Kawasaki disease. Clin Exp Immunol 2000; 121: 566-70.
39. MYERS D Jr, FARRIS D, HAWLEY A et al.: Selectins influence thrombosis in a mouse model of experimental deep venous thrombosis. J Surg Res 2002; 108: 212-21.
40. GUNNETT CA, HEISTAD DD, BERG DJ, FARACI FM: IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am J Physiol Heart Circ Physiol 2000; 279: H1555-62.
41. LEE T, SEO JW, SUMPIO BE, KIM SJ: Immunobiologic analysis of arterial tissue in Buerger's disease. Eur J Vasc Endovasc Surg 2003; 25: 451-7.
42. KOBAYASHI M, ITO M, NAKAGAWA A, NISHIKIMI N, NIMURA Y: Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J Vasc Surg 1999 29; 451-8.
43. COPPO R, BASOLO B, MARTINA G et al.: Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schonlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 1982; 18: 230-9.
44. BLOCKMANS D, BOBBAERS H: Inflammation phenomena in vasculitis: from immune complexes to less immune forms. Acta Clin Belg 1998; 53: 83-91.
45. HAMZAOUI K, HAMZAOUI A, GUEMIRA F, BESSIOUD M, HAMZA M, AYED K: Cytokine profile in Behcet's disease patients. Scand J Rheumatol 2002; 31: 205-10.
46. LORENZ HM, GRUNKE M, HIERONYMUS T et al.: Hyporesponsivness to gammac-chain cytokines in activated lymphocytes from patients with systemic lupus erythematosus leads to accelerated apoptosis. Eur J Immunol 2002; 32: 1253-63.